Results 171 to 180 of about 1,353,360 (263)
Vardenafil efficacy for the treatment of persistent pulmonary hypertension of the newborn. [PDF]
El-Hindi S.
europepmc +1 more source
Abstract Aim Mosliciguat (BAY 1237592), the first soluble guanylate cyclase (sGC) activator in a dry powder inhaler (DPI), could potentially treat pulmonary hypertension with a more targeted delivery than systemic sGC stimulators. We report safety and tolerability of mosliciguat in healthy men.
Johannes Nagelschmitz +7 more
wiley +1 more source
Fulminant Pulmonary Edema Triggered by Phenylephrine-Induced Hypertension for Early Neurological Deterioration in Ischemic Stroke. [PDF]
Kim SH, Choi JH, Choi B, Kim C.
europepmc +1 more source
Prior glucocorticoid exposure is associated with modestly increased vancomycin clearance in hospitalized children, partly mediated by renal function and inflammation and may contribute to subtherapeutic early drug exposure. Abstract Introduction Augmented renal clearance (ARC) can lead to subtherapeutic vancomycin exposure in children.
Kouki Tomari +6 more
wiley +1 more source
Treat, Reassess, Repair: Redefining Operability in Pulmonary Arterial Hypertension Associated With Atrial Septal Defect. [PDF]
Cramer JW.
europepmc +1 more source
Aims Pulmonary arterial hypertension (PAH) is a syndrome characterized by elevated pulmonary artery pressure. We developed a population pharmacokinetic (PPK) model using combined plasma drug concentration data from Japanese paediatric (<15 years) and adult (≥15 years) patients with PAH to investigate the pharmacokinetic characteristics of PAH ...
Motoyasu Miura +13 more
wiley +1 more source
Pulmonary hypertension in pregnancy: hemodynamic challenges, maternal risk, and multidisciplinary management. [PDF]
Chang SA.
europepmc +1 more source
Aims The glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) semaglutide and liraglutide are approved for chronic weight management. Both drugs also have favourable effects on the risk of developing diabetes and cardiovascular disease (CVD) compared with placebo, but their comparative effectiveness for these outcomes is unclear.
Ethan J. Cannon +7 more
wiley +1 more source
Twenty years of inhaler therapy: A nationwide drug utilization study
Aims This study aimed to map nationwide trends and prescribing patterns in inhaler use from 2004 to 2023. In light of evolving clinical guidelines and attention to the environmental impact of inhalers within recent years, we also examined variation in prescribing behaviour and patient‐level treatment choices. Methods Using nationwide health registries,
Katrine Bitsch Johansen +5 more
wiley +1 more source
AI-based prediction of pulmonary hypertension in COPD patients with cor pulmonale using clinical and CT features. [PDF]
Tan X +5 more
europepmc +1 more source

